Carlos Singer

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. pmc Dental anxiety and the use of oral health services among people attending two HIV primary care clinics in Miami
    Richard Singer
    College of Dental Medicine, Department of Orthodontics, Nova Southeastern University, Fort Lauderdale Davie, FL, USA
    Public Health Rep 127:36-44. 2012
  2. ncbi Adult-onset primary focal foot dystonia
    Carlos Singer
    Department of Neurology, Miller School of Medicine, University of Miami, 1501 NW 9th Avenue, Miami, FL 33136, USA
    Parkinsonism Relat Disord 12:57-60. 2006
  3. pmc The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
    Jeanne C Latourelle
    Department of Neurology, Boston University School of Medicine, Boston University, Boston, MA, USA
    BMC Med 6:32. 2008
  4. doi Is the G2019S LRRK2 mutation common in all southern European populations?
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida 33136, USA
    J Clin Neurosci 15:1027-30. 2008
  5. doi Giant arteriovenous malformation presenting as pediatric task-specific dystonia
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, 1501 NW 9th Avenue NPF, Miami, FL 33136, USA
    Neurology 70:1294. 2008
  6. doi Objective tremor registration during DBS surgery for essential tremor
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, United States
    Clin Neurol Neurosurg 111:376-9. 2009
  7. ncbi Melatonin MT1 and MT2 receptor expression in Parkinson's disease
    Nikhil Adi
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL, USA
    Med Sci Monit 16:BR61-7. 2010
  8. ncbi Case of pediatric acquired chronic hepatocerebral degeneration
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida 33136, USA
    Pediatr Neurol 38:67-70. 2008
  9. ncbi Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami FL, 33136, USA
    J Neuropsychiatry Clin Neurosci 18:113-6. 2006
  10. pmc Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL, USA
    Head Face Med 2:47. 2006

Detail Information

Publications64

  1. pmc Dental anxiety and the use of oral health services among people attending two HIV primary care clinics in Miami
    Richard Singer
    College of Dental Medicine, Department of Orthodontics, Nova Southeastern University, Fort Lauderdale Davie, FL, USA
    Public Health Rep 127:36-44. 2012
    ..We examined factors associated with dental anxiety among a sample of HIV primary care patients and investigated the independent association of dental anxiety with oral health care...
  2. ncbi Adult-onset primary focal foot dystonia
    Carlos Singer
    Department of Neurology, Miller School of Medicine, University of Miami, 1501 NW 9th Avenue, Miami, FL 33136, USA
    Parkinsonism Relat Disord 12:57-60. 2006
    ..Focal primary focal foot dystonia seems to be a rare form of focal dystonia with distinct clinical features that may benefit from treatment with botulinum toxin...
  3. pmc The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
    Jeanne C Latourelle
    Department of Neurology, Boston University School of Medicine, Boston University, Boston, MA, USA
    BMC Med 6:32. 2008
    ..Studies of the penetrance of LRRK2 mutations have produced a wide range of estimates, possibly due to differences in study design and recruitment, including in particular differences between samples of familial PD versus sporadic PD...
  4. doi Is the G2019S LRRK2 mutation common in all southern European populations?
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida 33136, USA
    J Clin Neurosci 15:1027-30. 2008
    ..Accurate estimations of the frequency and penetrance of different LRRK2 mutations are essential for correct and cost-efficient use of genetic testing and proper genetic counseling of patients with Parkinson's disease...
  5. doi Giant arteriovenous malformation presenting as pediatric task-specific dystonia
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, 1501 NW 9th Avenue NPF, Miami, FL 33136, USA
    Neurology 70:1294. 2008
  6. doi Objective tremor registration during DBS surgery for essential tremor
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, United States
    Clin Neurol Neurosurg 111:376-9. 2009
    ..Simple electronic tremor registration methods during DBS of the Vim nucleus of the thalamus may supplement the existing methodology that is solely based on subjective measures derived from clinical observations...
  7. ncbi Melatonin MT1 and MT2 receptor expression in Parkinson's disease
    Nikhil Adi
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL, USA
    Med Sci Monit 16:BR61-7. 2010
    ..Although the role of melatonin, a potent endogenous antioxidant, has been highlighted in PD there is no data on the expression of melatonin receptors in affected CNS regions...
  8. ncbi Case of pediatric acquired chronic hepatocerebral degeneration
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida 33136, USA
    Pediatr Neurol 38:67-70. 2008
    ..The pediatric phenotype of acquired chronic hepatocerebral degeneration is presented, and the differential diagnosis in regard to Wilson's disease and management alternatives are discussed...
  9. ncbi Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami FL, 33136, USA
    J Neuropsychiatry Clin Neurosci 18:113-6. 2006
    ..Findings suggest that positive family history for dementia is associated with DLB with a yet unknown mechanism...
  10. pmc Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL, USA
    Head Face Med 2:47. 2006
    ..We present here the clinical characteristics and treatment variables of a series of patients that developed an OMD-associated eating dysfunction...
  11. ncbi Anterocollis: clinical features and treatment options
    Spiridon Papapetropoulos
    Department of Neurology, Division of Movement Disorders, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Med Sci Monit 14:CR427-30. 2008
    ..It has been mainly described in the context of parkinsonian movement disorders including Parkinson's disease and multiple system atrophy...
  12. ncbi Botulinum toxin in movement disorders
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida 33136, USA
    Semin Neurol 27:183-94. 2007
    ..However, controlled studies for many conditions are lacking, and more clinical trials in many different areas are warranted...
  13. ncbi Primary writing tremor: report of a case successfully treated with botulinum toxin A injections and discussion of underlying mechanism
    Carlos Singer
    Department of Neurology, University of Miami School of Medicine, Miami, Florida 33136, USA
    Mov Disord 20:1387-8. 2005
    ..We describe a patient with PWT, present a video before and after successful treatment with botulinum toxin type A injections, and discuss a possible underlying dystonic mechanism...
  14. pmc Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease
    Rodger J Elble
    Department of Neurology, Southern Illinois University School of Medicine, Springfield, Illinois, USA
    Mov Disord 25:1082-6. 2010
    ..We found the investigators' level of confidence in these agents had no effect on the time to symptomatic therapy or on the change in UPDRS during 12 months of treatment...
  15. ncbi Lower limb post-immobilization dystonia in Parkinson's disease
    Carlos Singer
    Department of Neurology, University of Miami, Miller School of Medicine, School of Medicine 1501 NW 9th Avenue Miami, FL 33136, USA
    J Neurol Sci 239:111-4. 2005
    ..Post-immobilization dystonia of lower limbs in PD is resistant to medical treatment and leads to significant functional disability. Botulinum toxin may provide partial relief in some cases and orthopedic surgery can also be considered...
  16. ncbi Treatment of primary writing tremor with botulinum toxin type a injections: report of a case series
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Clin Neuropharmacol 29:364-7. 2006
    ..One patient declined botulinum toxin injections and responded moderately when treated with trihexyphenidyl...
  17. ncbi A case of painless arms/moving fingers responsive to botulinum toxin a injections
    Carlos Singer
    Department of Neurology, Miller School of Medicine, University of Miami, 1501 NW 9th Avenue NPF, Room 4004, Miami, FL 33136, USA
    Parkinsonism Relat Disord 13:55-6. 2007
    ..The presence of dystonic symptoms in our case argues in favor of a possible implication of a dystonic mechanism in at least some cases of PLME...
  18. doi Gene-environment interactions in Parkinson's disease and other forms of parkinsonism
    Jeffery M Vance
    University of Miami, Miami, FL 33101, USA
    Neurotoxicology 31:598-602. 2010
    ..Thus, toxicant-alpha-synuclein interactions could have deleterious consequences and play a role in pathogenetic processes in human parkinsonism...
  19. doi A myxoid chondrosarcoma associated with an anti-Hu-positive paraneoplastic encephalomyelitis
    Michael Hoosien
    University of Miami, Miami, FL, 33136, USA
    J Neurooncol 101:135-9. 2011
    ....
  20. doi Managing the patient with newly diagnosed Parkinson disease
    Carlos Singer
    Center for Parkinson s disease and Movement Disorders, Clinical Research Building, Leonard M Miller School of Medicine, University of Miami, 1120 NW 14th Street, 13th Floor, Miami, FL 33136, USA
    Cleve Clin J Med 79:S3-7. 2012
    ..Deep brain stimulation may slow cognitive and motor decline when used in early PD. Stem cell therapy and gene therapy are still under investigation...
  21. doi Cardiac denervation and dysautonomia in Parkinson's disease: a review of screening techniques
    Kathryn K Post
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Clinical Research Building, 1120 N W 14th Street, 13th Floor, Room 1349, Miami, FL 33136, USA
    Parkinsonism Relat Disord 14:524-31. 2008
    ..We give one possible example of such a variable in this paper using heart transplant patients as a model...
  22. pmc A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease
    Spiridon Papapetropoulos
    Divisions of Movement Disorders Department of Neurology, University of Miami, Miller School of Medicine Miami, FL, USA
    BMC Neurol 8:21. 2008
    ..To this end, we developed the University of Miami Parkinson's disease Hallucinations Questionnaire (UM-PDHQ) that allows comprehensive assessment of hallucinations in clinical or research settings...
  23. pmc Objective quantification of neuromotor symptoms in Parkinson's disease: implementation of a portable, computerized measurement tool
    Spyridon Papapetropoulos
    Department of Neurology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Parkinsons Dis 2010:760196. 2010
    ..More work is warranted to establish CATSYS as a diagnostic/monitoring instrument in movement disorders using the proposed technical approaches...
  24. ncbi Retrocollis: classification, clinical phenotype, treatment outcomes and risk factors
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Eur Neurol 59:71-5. 2008
    ..7%). Of patients injected with botulinum toxin type A, 24.5% reported excellent, 32.1% moderate, 16.9% mild and 24.5% no response to injections. Oral antidystonic medications had limited contribution to symptom relief...
  25. ncbi A progressive, fatal dystonia-Parkinsonism syndrome in a patient with primary immunodeficiency receiving chronic IVIG therapy
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida 33136, and Massachusetts General Hospital, Boston, USA
    Mov Disord 22:1664-6. 2007
    ..Physician awareness of this rare syndrome may lead to its better characterization and management...
  26. ncbi [Parkinsonism: alternative diagnosis beyond idiopathic Parkinson's disease]
    Jose Gutierrez
    Leonard M Miller School of Medicine, Department of Neurology, University of Miami, USA
    Rev Med Inst Mex Seguro Soc 48:279-92. 2010
    ..This review gives a general landscape of Parkinsonism and its most likely differentials...
  27. pmc Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study
    Christopher F McNicoll
    Department of Neurology, Boston University School of Medicine, Boston University, Boston, Massachusetts 02118, USA
    Mov Disord 23:1596-601. 2008
    ..No relation between the HD CAG repeat size and the age at onset for PD was found in this sample of familial PD...
  28. doi Contemporary Encephalitis Lethargica: phenotype, laboratory findings and treatment outcomes
    Robert Lopez-Alberola
    Dept of Pediatrics, University of Miami, Miller School of Medicine, Miami 33136, USA
    J Neurol 256:396-404. 2009
    ..Against this background we conducted a study aiming to elucidate the clinical characteristics, describe laboratory/ neuroimaging findings (MRI, PET) and present treatment options and outcomes in sporadic EL...
  29. ncbi Painless legs moving toes in a patient with Wilson's disease
    Spiridon Papapetropoulos
    Department of Neurology University of Miami, Miller School of Medicine, FL 33136, USA
    Mov Disord 21:579-80. 2006
    ..We suggest that, in our case, a structural central nervous system lesion caused by WD may have been associated with the development of PLMT...
  30. ncbi Childhood-onset hemifacial spasm: successful treatment with botulinum toxin
    Carlos Singer
    Department of Neurology, University of Miami, School of Medicine, Miami, Florida 33136, USA
    Pediatr Neurol 33:220-2. 2005
    ..This report presents the first case of a pediatric patient with childhood-onset hemifacial spasm successfully treated with periorbital botulinum toxin injections. The literature on the subject is also reviewed...
  31. ncbi Clinical heterogeneity of the LRRK2 G2019S mutation
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami School of Medicine, Miami, FL, USA
    Arch Neurol 63:1242-6. 2006
    ..The "common" LRRK2 G2019S kinase domain substitution has been reported to account for approximately 5% of familial and 1% of sporadic Parkinson disease...
  32. ncbi A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia
    Carlos Singer
    Miller School of Medicine, Department of Neurology University of Miami, 1501 NW 9th Avenue NPF, Room 4004, Miami, FL 33136, USA
    Parkinsonism Relat Disord 12:115-8. 2006
    ..Male gender, orobuccolingual dyskinesias (facial grimacing, lip biting, tongue dyskinesias, platysma contractions and bruxism) and better response to botulinum toxin injections were more frequent in C-OMD but remained a trend...
  33. ncbi Case of maternally transmitted juvenile Huntington's disease with a very large trinucleotide repeat
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, School of Medicine, Miami, Florida 33136, USA
    Mov Disord 20:1380-3. 2005
    ..Maternally transmitted very large trinucleotide repeats (>100) are extremely rare in juvenile HD and may represent instability during female gametogenesis...
  34. ncbi Primary craniocervical dystonia presenting as a respiratory emergency
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, 1501 NW 9th Avenue NPF, Room 4004, Miami, FL 33136, USA
    Neurology 68:388-9. 2007
  35. ncbi Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP)
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Parkinsonism Relat Disord 11:459-63. 2005
    ..Deaths that occurred during winter and spring months accounted for about 70% of deaths among PSP patients. The most common co-morbid condition in PSP was hypertension, present in 50% of cases...
  36. ncbi Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study
    Samer Karamohamed
    Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
    Mov Disord 20:1188-91. 2005
    ..None of the variants were found in the GenePD families. Our results suggest that other variants or genes account for the familial risk of PD within the GenePD study...
  37. doi Comprehensive treatment of Huntington disease and other choreic disorders
    Carlos Singer
    Center for Parkinson s disease and Movement Disorders, Leonard M Miller School of Medicine, University of Miami, Miami, FL 33136, USA
    Cleve Clin J Med 79:S30-4. 2012
    ..Caring for the caregiver is also a significant concern in the long-term treatment of choreic disorders...
  38. ncbi A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease
    Carlos Singer
    Department of Neurology, University of Miami, Miami, Florida, USA
    Mov Disord 22:476-82. 2007
    ..Noninferiority of sumanirole to ropinirole was not demonstrated, with a difference of 2.70 (90% CI, 0.92-4.49). Sumanirole was better tolerated than ropinirole...
  39. ncbi Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series
    Carlos Singer
    Department of Neurology University of Miami, School of Medicine, Miami, Florida 33136, USA
    Mov Disord 20:873-7. 2005
    ..Our results demonstrate that rimantadine may be considered as an alternative to amantadine in patients experiencing amantadine-induced peripheral side effects...
  40. ncbi Cervical dystonia: etiology and pathophysiology
    Carlos Singer
    Division of Movement Disorders, Miller School of Medicine, University of Miami, 1501 NW 9th Avenue, Miami, FL 33136, USA
    Neurol Clin 26:9-22. 2008
  41. pmc PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study
    Anita L Destefano
    Department of Neurology, Boston University Schools of Medicine and of Public Health, Boston, MA 02118, USA
    Am J Hum Genet 70:1089-95. 2002
    ....
  42. pmc Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease
    Todd L Edwards
    John P Hussman Institute for Human Genomics, University of Miami, FL 33136, USA
    Ann Hum Genet 74:97-109. 2010
    ..79] T vs. C allele, PAR%= 8%) were genome-wide significant. No other SNPs were genome-wide significant in this analysis. This study confirms that SNCA and the MAPT region are major genes whose common variants are influencing risk of PD...
  43. ncbi Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD)
    Spiridon Papapetropoulos
    Mov Disord 20:1088-9. 2005
  44. ncbi Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis
    Carlos Singer
    Mov Disord 22:289. 2007
  45. ncbi Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study
    Daniel Truong
    The Parkinson s and Movement Disorders Institute, Fountain Valley, California 92708, USA
    Mov Disord 20:783-91. 2005
    ..These results confirm previous reports that Dysport (500 units) is safe, effective, and well-tolerated in patients with cervical dystonia...
  46. pmc Replication of association between ELAVL4 and Parkinson disease: the GenePD study
    Anita L Destefano
    Department of Biostatistics, Boston University School of Public Health, 715 Albany Street, Crosstown Center, 3rd Floor, Boston, MA 02118, USA
    Hum Genet 124:95-9. 2008
    ..This replication of association with rs967582 in a third cohort further implicates ELAVL4 as a PD susceptibility gene...
  47. doi Treatment of painful limbs/moving extremities with botulinum toxin type A injections
    Mahmood Eisa
    Eur Neurol 60:104-6. 2008
  48. ncbi Does cigarette smoking provide clinically significant neuroprotection among patients diagnosed with Parkinson's disease?
    Spiridon Papapetropoulos
    Mov Disord 20:641-2. 2005
  49. ncbi Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study
    Mei Sun
    Molecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
    Arch Neurol 63:826-32. 2006
    ..The PARK2 gene at 6q26 encodes parkin, whose inactivation is implicated in an early-onset autosomal recessive form of Parkinson disease (PD)...
  50. ncbi Lower facial and neck dystonia after a cosmetic surgical procedure: report of a case
    Spiridon Papapetropoulos
    Mov Disord 21:125-6. 2006
  51. ncbi Bilateral mirror writing movements (mirror dystonia) in a patient with writer's cramp: Functional correlates
    Spiridon Papapetropoulos
    Mov Disord 22:149. 2007
  52. ncbi Tardive dystonia associated with ziprasidone
    Spiridon Papapetropoulos
    Am J Psychiatry 162:2191. 2005
  53. ncbi Laryngeal dystonia as a presenting symptom of young-onset Parkinson's disease
    Spiridon Papapetropoulos
    Mov Disord 22:1670-1. 2007
  54. ncbi Cervical dystonia as a presenting symptom of Parkinson's disease
    Spiridon Papapetropoulos
    Parkinsonism Relat Disord 12:514-6. 2006
  55. ncbi Moving fingers associated with Dupuytren's disease: a case report
    Spiridon Papapetropoulos
    Eur Neurol 59:96-7. 2008
  56. ncbi Pain-pressure threshold in patients with Parkinson's disease with and without dyskinesia
    Lydia Vela
    Unit of Neurology, Fundacion Hospital Alcorcon, C Budapest, Alcorcon 28922, Madrid, Spain
    Parkinsonism Relat Disord 13:189-92. 2007
    ..No differences were found in PPT between controls and PD patients with or without dyskinesia. Patients and control women had a lower PPT than men. In conclusion, the presence of dyskinesia in PD patients does not appear to decrease PPT...
  57. ncbi Staged unilateral or bilateral STN-DBS?
    Spiridon Papapetropoulos
    Mov Disord 23:775. 2008
  58. ncbi Primary focal lingual dystonia
    Spiridon Papapetropoulos
    Mov Disord 21:429-30. 2006
  59. doi A formula for the conversion of UPDRS-III scores to Hoehn and Yahr stage
    Blake K Scanlon
    Parkinsonism Relat Disord 14:379-80. 2008
  60. ncbi Improvement of cervico-trunco-brachial segmental dystonia with topiramate
    Spiridon Papapetropoulos
    J Neurol 253:535-6. 2006
  61. pmc Caffeine and progression of Parkinson disease
    David K Simon
    Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA
    Clin Neuropharmacol 31:189-96. 2008
    ..We assessed this relationship using data from 2 recent clinical trials of PD...
  62. doi Transtelephonic home blood pressure to assess the monoamine oxidase-B inhibitor rasagiline in Parkinson disease
    William B White
    Division of Hypertension and Clinical Pharmacology, Pat and Jim Calhoun Cardiology Center and Clinical Trials Unit, University of Connecticut, Farmington, Connecticut 06030 3940, USA
    Hypertension 52:587-93. 2008
    ..3%, 2.6%, and 2.9% of the placebo, 0.5-mg, and 1.0-mg rasagiline groups, respectively. These data demonstrate that rasagiline did not induce postprandial hypertension in patients with Parkinson disease who were on an unrestricted diet...
  63. ncbi Sporadic geniospasm (chin trembling): report of a case
    Spiridon Papapetropoulos
    Mov Disord 22:434. 2007